🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, multicenter, double-blind, placebo-controlled, parallel-gr...
Status
Completed
Location
University Alabama At Birmingham
Start Date
2013-10-13
Trial ID
NCT01872689
Treatments Being Tested
The purpose of this study is to measure how well taking lebrikizumab alone ...
Status
Active Not Recruiting
Location
Total Skin & Beauty Dermatology Center, PC DBA Total Dermatology
Start Date
2025-06-16
Trial ID
NCT07006792
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Completed
Location
Investigate MD
Start Date
2019-10-29
Trial ID
NCT04178967
Treatments Being Tested
The purpose of this study is to determine the safety and effectiveness of T...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-05
Trial ID
NCT00441818
Treatments Being Tested
The main purpose of this study is to assess the efficacy of lebrikizumab ve...
Status
Completed
Location
First OC Dermatology Research Inc
Start Date
2025-04-21
Trial ID
NCT06921759
Treatments Being Tested
The main purpose of this study is to look at the amount of the study drug, ...
Status
Completed
Location
LabCorp CRU, Inc.
Start Date
2021-06-02
Trial ID
NCT04840901
Treatments Being Tested
This randomized, multicenter, double-blind, placebo-controlled, parallel-gr...
Status
Completed
Location
Alabama Clinical Research Associates
Start Date
2013-07-25
Trial ID
NCT01867125
Treatments Being Tested
The primary objective for this study is to evaluate the safety of lebrikizu...
Status
Completed
Location
T. Joseph Raoof Md, Inc.
Start Date
2015-07-30
Trial ID
NCT02465606
This study will assess the bioequivalence in healthy participants between a...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02486809
Treatments Being Tested
The main purpose of this study is to determine the tolerability and side ef...
Status
Completed
Location
Peking University People's Hospital
Start Date
2024-03-28
Trial ID
NCT06243198
Treatments Being Tested